Hepion Pharmaceuticals Inc (NASDAQ:HEPA)

3.43
Delayed Data
As of Sep 18
 -0.17 / -4.72%
Today’s Change
1.00
Today|||52-Week Range
8.35
-36.01%
Year-to-Date
SRNE, IMGN among premarket gainers
Sep 17 / Seeking Alpha - Paid Partner Content
Hepion Pharma completes final dosing in multiple ascending dose study of CRV431
Sep 01 / Seeking Alpha - Paid Partner Content
Hepion's lead drug shows antiviral activity against COVID-19
Sep 17 / Seeking Alpha - Paid Partner Content